TOMZD TOMI Environmental Solutions I

Tomi CEO Dr. Halden Shane to Present at the H.C. Wainwright Global Investment Conference

Tomi CEO Dr. Halden Shane to Present at the H.C. Wainwright Global Investment Conference

FREDERICK, Md., Sept. 08, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced that Dr. Halden Shane, Chief Executive Officer, will be presenting virtually at the H.C. Wainwright 24th Annual Global Investment Conference to be held September 12-14, 2022.

Dr. Shane’s presentation will be pre-recorded and accessible at the start of the conference on Monday, September 12. Interested investors can register to access the presentation at this . The Company will also be available for one-on-one meetings throughout the conference.

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world® 

TOMI™ Environmental Solutions, Inc. (NASDAQ: ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP). Represented by the SteraMist® brand of products, iHP produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit  or contact us at .

INVESTOR RELATIONS CONTACT



John Nesbett/Jennifer Belodeau

IMS Investor Relations



EN
08/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TOMI Environmental Solutions I

 PRESS RELEASE

TOMI Environmental Solutions Receives Biocidal Product Approvals in Gr...

TOMI Environmental Solutions Receives Biocidal Product Approvals in Great Britain and Northern Ireland Health and Safety Executive (HSE) grants Authorization Nos.: GB-2016-1042 and NI-2026-1350 FREDERICK, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced that Health and Safety Executive (HSE), Great Britian’s national regulator for health and safety, has granted official authorization for its Binary Ionization Technology (BIT) solution and the SteraMist iHP brand of...

 PRESS RELEASE

TOMI Environmental Solutions Secures UK CES contract integrating Stera...

TOMI Environmental Solutions Secures UK CES contract integrating SteraMist iHP into Total Clean Air's Modular Cleanroom Platform FREDERICK, Md., Jan. 20, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced the sale of a Custom Engineered System (CES) in the United Kingdom to an international pharmaceutical manufacturing organization. The system is being delivered as part of a bespoke, modular cleanroom platform designed, engineered, and validated by Total Clean Air Limited (“T...

 PRESS RELEASE

Prestigious Research University Integrates SteraMist Hybrid System for...

Prestigious Research University Integrates SteraMist Hybrid System for Advanced Medical Product Sterilization FREDERICK, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today the purchase of its SteraMist Hybrid System within a new facility of a private research university on the East Coast. This installation ensures the rigorous safety and sterilization of reusable medical equipment bound for patient homes. In the pursuit of high-level, reliable decontamination cr...

 PRESS RELEASE

TOMI Environmental Solutions Expands Footprint in Cell and Gene Therap...

TOMI Environmental Solutions Expands Footprint in Cell and Gene Therapy Sector with Multi-Stage SteraMist iHP Implementation at a New Pharmaceutical Manufacturing Site FREDERICK, Md., Dec. 22, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that a leading Cell and Gene Therapy (CGT) manufacturer has adopted SteraMist ionized Hydrogen Peroxide (iHP) technology for its commercial-scale facility. This multi-staged implementation strengthens the facility’s Contamination Control...

 PRESS RELEASE

TOMI Environmental Solutions Secures a Purchase Order of Approximately...

TOMI Environmental Solutions Secures a Purchase Order of Approximately $500,000 for the Integration of SteraMist iHP Technology within a Global Biopharmaceutical Leader FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today announced it has received a significant signed purchase contract including a purchase order valued at approximately $500,000 from one of the world's largest and most respected biopharmaceutical companies. This order is for the complete ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch